Lucas M. Saposnik

General San Martin, B, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Zinc starvation uncovers bacterial host-specific proteases that shape NDM adaptability in Acinetobacter baumannii.

Zinc starvation uncovers bacterial host-specific proteases that shape NDM adaptability in Acinetobacter baumannii.

Journal: mBio
Published: December 08, 2025

Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity.

Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity.

Journal: NPJ vaccines
Published: February 10, 2025

Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial.

Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial.

Journal: Vaccine
Published: November 15, 2024

Ecotin protects Salmonella Typhimurium against the microbicidal activity of host proteases.

Ecotin protects Salmonella Typhimurium against the microbicidal activity of host proteases.

Journal: PLoS pathogens
Published: June 20, 2024

Ecotin protects Salmonella Typhimurium against the microbicidal activity of host proteases.

Ecotin protects Salmonella Typhimurium against the microbicidal activity of host proteases.

Journal: bioRxiv : the preprint server for biology
Published: May 27, 2024

Regulation of human neutrophil IL-1β secretion induced by Escherichia coli O157:H7 responsible for hemolytic uremic syndrome.

Regulation of human neutrophil IL-1β secretion induced by Escherichia coli O157:H7 responsible for hemolytic uremic syndrome.

Journal: PLoS pathogens
Published: August 09, 2023

Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults.

Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults.

Journal: Nature communications
Published: February 17, 2023

A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection.

A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection.

Journal: Nature communications
Published: February 01, 2023

A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice.

A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice.

Journal: Frontiers in immunology
Published: December 28, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026